TLR9 and cancer: It has also been demonstrated that stimulation of TLR9-expressing cancer cells with synthetic TLR9-ligands increases their in vitro invasion which is associated with the down-regulation of tissue inhibitor of metalloproteinases-3 (TIMP3) and the up-regulation of matrix metalloproteinase-13 (MMP-13) activity.